The Council of the EU (Foreign Affairs) approved on 21 June the EU Drugs Action Plan for 2021–2025. The new plan presents the concrete actions needed to achieve the priorities of the EU Drugs Strategy, adopted in December 2020 (1).
The action plan sets out a specific timetable for these actions, a list of responsible parties and a series of indicators to measure effectiveness. The plan was prepared by national and EU representatives on the Council’s Horizontal Working Party on Drugs (HDG) under the Portuguese Presidency of the EU.
With the current EU Drugs Strategy, the EU and its Member States reaffirm their commitment to a balanced, evidence-based approach to address the drug phenomenon in Europe, with the preservation of human rights at its core. The strategy draws on lessons learned from the COVID-19 pandemic in the drugs area and takes a future-oriented approach, promoting research, innovation and foresight to respond more effectively to, and anticipate, forthcoming challenges.
